(Q42190258)

18 October 2017

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice (English)

1 reference

18 October 2017

V K Goel

1

1 reference

18 October 2017

N Ibrahim

2

1 reference

18 October 2017

G Jiang

3

1 reference

18 October 2017

M Singhal

4

1 reference

18 October 2017

S Fee

5

1 reference

18 October 2017

T Flotte

6

1 reference

18 October 2017

S Westmoreland

7

1 reference

18 October 2017

F S Haluska

8

1 reference

18 October 2017

P W Hinds

9

1 reference

18 October 2017

F G Haluska

10

1 reference

18 October 2017

language of work or name

English

0 references

publication date

27 April 2009

1 reference

18 October 2017

1 reference

18 October 2017

28

1 reference

18 October 2017

23

1 reference

18 October 2017

2289-2298

1 reference

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Genetic alterations in signaling pathways in melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Distinct sets of genetic alterations in melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

BRAFE600-associated senescence-like cell cycle arrest of human naevi

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Deregulated Akt3 activity promotes development of malignant melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

PTEN signaling pathways in melanoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

High frequency of BRAF mutations in nevi

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Dual inactivation of RB and p53 pathways in RAS-induced melanomas

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Cooperative effects of INK4a and ras in melanoma susceptibility in vivo

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

A negative feedback signaling network underlies oncogene-induced senescence

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Amplification of CDK4 and MDM2 in malignant melanoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial-derived tissues

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

A genome-based strategy uncovers frequent BRAF mutations in melanoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

p16(Ink4a) in melanocyte senescence and differentiation.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Role of the INK4a locus in tumor suppression and cell mortality.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125533

Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61Kon an INK4a-Deficient Background

17 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.95

Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.95

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.95

Normal murine melanocytes in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.95

Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.95

Suppression of BRAF(V599E) in human melanoma abrogates transformation

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19398955

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2009.95

1 reference

Dimensions Publication ID

18 October 2017

0 references

1 reference

18 October 2017

PubMed publication ID

19398955

1 reference